The journal retracts the article “FBXW7 Acts as an Independent Prognostic Marker and Inhibits Tumor Growth in Human Osteosarcoma” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding a number of irregularities found in images presented in this article [1].
Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board, which confirmed indications of inappropriate image editing regarding an overlap between Figures 3D and 5 published in [1] and Figures 1A and 6B published in [2]; between Figure 3D in [1] and Figure 2D presented in [3] and Figure 4C [4]; between Figures 4B,C and 5 published in [1] and Figures 4B and 5B published in [5]; and between Figure 4A in [1] and Figure 4A published in [6], all showing different experimental conditions. As a result, the Editorial Board has lost confidence in the reliability of the findings and decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 29 March 2026).
This retraction was approved by the Editor-in-Chief of IJMS.
The authors did not provide a comment on this decision.
References
- Li, Z.; Xiao, J.; Hu, K.; Wang, G.; Li, M.; Zhang, J.; Cheng, G. RETRACTED: FBXW7 Acts as an Independent Prognostic Marker and Inhibits Tumor Growth in Human Osteosarcoma. Int. J. Mol. Sci. 2015, 16, 2294–2306. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tu, K.; Yang, W.; Li, C.; Zheng, X.; Lu, Z.; Guo, C.; Yao, Y.; Liu, Q. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Mol. Cancer 2014, 13, 110. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zheng, X.; Gai, X.; Ding, F.; Lu, Z.; Tu, K.; Yao, Y.; Liu, Q. Histone acetyltransferase PCAF up-regulated cell apoptosis in hepatocellular carcinoma via acetylating histone H4 and inactivating AKT signaling. Mol. Cancer 2013, 12, 96, Correction in Mol. Cancer 2022, 21, 187. https://doi.org/10.1186/s12943-022-01637-2. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tu, K.; Zheng, X.; Zhou, Z.; Li, C.; Zhang, J.; Gao, J.; Yao, Y.; Liu, Q. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. PLoS ONE 2013, 8, e68574, Retraction in PLoS ONE 2020, 15, e0231287. https://doi.org/10.1371/journal.pone.0231287. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tu, K.; Li, C.; Zheng, X.; Yang, W.; Yao, Y.; Liu, Q. Prognostic significance of miR-218 in human hepatocellular carcinoma and its role in cell growth. Oncol. Rep. 2014, 32, 1571–1577. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Huang, Y.; Guo, W.; Kan, H. TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma. Int. J. Mol. Sci. 2014, 15, 18148–18161. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.